No Cyclophosphamide+Bortezomib+Dexamethasone (NO CVD), Alkylating Agents, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Cyclophosphamide+Bortezomib+Dexamethasone (CVD)
### Instruction:
Identify the study with the following condition. 
### Input:
No Cyclophosphamide+Bortezomib+Dexamethasone (NO CVD), Alkylating Agents, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Cyclophosphamide+Bortezomib+Dexamethasone (CVD) 
### Output:
Popular Name is Myeloma XI, Study ID is NCT01554852